Who invested in Convergence Pharmaceuticals?
Convergence Pharmaceuticals's investors include SV Life Sciences, New Leaf Venture Partners, SV Health Investors and Apposite Capital.
United Kingdom · Series A startup
Funding summaryUpdated 26 Oct 2026
$35Mraised across 1 round since 2010, from 1 source
Reported by finsmes.com
From historical deal records. Wrong? Tell us.
Convergence Pharmaceuticals's investors include SV Life Sciences, New Leaf Venture Partners, SV Health Investors and Apposite Capital.
Convergence Pharmaceuticals has raised $35M across 1 round since 2010.
Convergence Pharmaceuticals's most recent round was a Series A of $35M in Oct 2010.
Its most recent round, $35M in Oct 2010, is also its largest on record.
Convergence Pharmaceuticals's first round on record, in Oct 2010, was backed by SV Life Sciences, New Leaf Venture Partners and SV Health Investors and 1 others.
Convergence Pharmaceuticals's latest named round is a Series A, in Oct 2010.
Convergence Pharmaceuticals is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.